Someone in my ADHD support group spent $1,200 last year on supplements. Not medication. Not therapy. Supplements that a popular ADHD influencer swore had “changed everything.”

I’ve done versions of this too. Different amounts, different products. The pattern is familiar: you read something that resonates, the testimonials are real people with real brains like yours, and you think maybe this is the thing that finally clicks. Except it usually doesn’t, and you’re out money and months of hope.

A research team just published something that makes this kind of guesswork unnecessary. A review drawing on more than 200 meta-analyses, the largest synthesis of ADHD treatment evidence ever conducted, ranked 31 interventions by actual evidence quality. Then they built a free public website so you can look up any treatment before you spend a dollar on it.

TL;DR

What	The short version
The review	221 meta-analyses, 31 interventions, published in The BMJ
Strongest evidence	Stimulant meds (kids + adults), CBT (adults), atomoxetine
Only non-med with large long-term effects	Mindfulness, but with low certainty evidence
The free tool	ebiadhd-database.org — filter by age, outcome, treatment
What the researchers flagged	Widespread misinformation is costing patients real time and money

Bottom line: Medications and CBT have the strongest evidence. Most supplements and popular alternatives don’t. The free tool lets you check anything before committing to it.

The Misinformation Problem Is Bigger Than You Think

The research team didn’t just publish the evidence. They specifically called out misinformation as a major driver of poor treatment decisions.

ADHD communities online (Reddit, TikTok, Facebook groups) are full of passionate people sharing what worked for them. That’s not malicious. But individual experience spreads faster than population-level data. One person’s dramatic omega-3 success story gets 4,000 upvotes. The systematic review showing no significant effect for core symptoms gets a 12-paragraph thread that loses everyone by paragraph three.

The gap between what ADHD patients believe works and what the evidence supports is real and documented. Patients are wasting time, money, and sometimes safety on approaches that haven’t cleared even basic evidence bars. And they’re often skeptical of the interventions that have.

What the Review Actually Found

The study analyzed 221 separate meta-analyses, each of which was already a synthesis of multiple clinical trials. They ran everything through a standardized statistical pipeline so different interventions could be compared directly. Then they published results across 24 different clinical outcomes.

Here’s what came out:

For children: Stimulant medications (amphetamines, methylphenidate) showed the strongest evidence by a clear margin. Alpha-2 agonists and atomoxetine also showed solid short-term results. Nothing in the non-medication category came close for children.

For adults: Stimulants still hold up. Atomoxetine shows moderate-to-high certainty evidence. CBT for adults has strong support, genuinely comparable to medication in evidence quality, which surprised a lot of people when this was published.

The long-term gap: Almost zero high-certainty evidence exists for any intervention over periods longer than months. This is uncomfortable but worth knowing. It doesn’t mean long-term treatment doesn’t work. It means the research trials haven’t run long enough to prove it at the same standard.

CBT for Adults: The Finding That Gets Undersold

Most coverage of this review leads with medication. The CBT finding deserves more attention.

For adults, CBT showed medium effect sizes with moderate-to-high certainty evidence. That’s a rare combination in ADHD research: strong effect and reliable methodology. The mechanism matters too: ADHD-specific CBT isn’t generic talk therapy. It targets task initiation, avoidance patterns, and the executive function gaps that make everyday systems fall apart.

The emotional layer matters. Decades of ADHD without diagnosis or support leaves a specific kind of damage. Shame about forgotten tasks, hypervigilance about “failing again,” relationships strained by executive function gaps. CBT for ADHD addresses this directly in a way that medication alone doesn’t.

If you’ve built a solid productivity stack but still hit the same walls, this is likely where the ceiling is.

The Attexis digital CBT trial covered an RCT showing d=0.85 effects for adult ADHD. That result sits on the same evidence foundation this review confirms.

Mindfulness: The Surprising Long-Term Signal

This one needs careful handling.

Mindfulness showed up as the only non-medication intervention with large effects at extended follow-up. That’s genuinely interesting, and it’s been cited in a few places as a reason to take mindfulness more seriously for ADHD.

The catch: evidence quality was low. Small studies, higher bias risk, inconsistent measurement across trials. “Large effect size with low certainty evidence” doesn’t mean the effect is real. It means the studies that exist showed big numbers, but the research isn’t rigorous enough to trust those numbers yet.

If mindfulness already works for you, keep it. The data doesn’t say it doesn’t work. But replacing your current stack with mindfulness because of this finding isn’t what the evidence actually supports.

What the Interactive Tool Lets You Do

The free database at ebiadhd-database.org is the most practically useful part of this research release.

Before this existed, reading the actual evidence required journal access and enough statistical literacy to interpret forest plots. The tool removes both barriers.

What you can do in 15 minutes:

1. Go to ebiadhd-database.org/wizard
2. Choose your mode: compare specific interventions, or build a profile by age group and outcome
3. Select your age group (the evidence differs substantially between children and adults)
4. Click any treatment-outcome cell to see effect size, number of studies behind it, and certainty rating in plain English

I specifically looked up four things I’d seen recommended in ADHD communities: omega-3 supplements, neurofeedback, a branded nootropic, and CBT. The gap between their community reputations and their evidence ratings was significant. Neurofeedback in particular, a topic that generates enormous enthusiasm and expensive devices, showed low certainty with effects that largely disappear against active controls.

That’s not information you’d easily find without this tool.

The Shared Decision-Making Angle

The platform was built specifically for shared decision-making, and that framing changes how you use it.

Shared decision-making means: you come to a clinical appointment with the same evidence your doctor is working from. Not to argue. To have a real conversation where your preferences, values, and specific situation shape the final choice, alongside the population-level evidence.

For ADHD, this matters in concrete ways. Stimulants are the strongest evidence-based option. They’re also not viable for everyone. Cardiac contraindications, history of certain conditions, some jobs, some personal choices all play into that. The evidence strongly supports medication without saying every single person should take it. Your doctor needs your context. You need their evidence base. The tool makes that exchange possible.

Research shows that shared decision-making specifically improves treatment adherence and outcomes over time. Knowing why your treatment plan was chosen, and having a real say in it, changes how you maintain it when things get hard.

The ADHD medication science post covers how stimulants interact with dopamine systems. That context helps you understand what you’re seeing in the evidence matrix when you filter for specific outcomes.

What This Means If You Can’t or Don’t Take Medication

I manage ADHD without medication. The question I always have when a medication-heavy study comes out is: what does this mean for people in my situation?

The honest answer from this review:

CBT is your strongest documented option. The evidence quality for adult CBT is genuinely comparable to medication evidence. If you haven’t engaged with ADHD-specific CBT (not generic therapy, but structured CBT designed for ADHD executive function), the data says this is the most evidence-backed thing you can do.

Exercise is worth including as part of a system, not as a primary treatment. The mechanistic case is real (dopamine, norepinephrine, executive function support), but the research quality doesn’t support calling it a reliable standalone intervention.

Most supplements don’t have the evidence. Omega-3 for core ADHD symptoms: conflicting, low-certainty results. This is the hardest finding for a lot of people because omega-3 supplementation has been marketed to ADHD communities aggressively for years. The current evidence doesn’t justify it as a primary spend.

The accommodations layer (apps, systems, external memory tools) sits outside what this database measures. The best working memory tools guide and best AI ADHD coaching apps operate on the practical accommodation level. Clinical evidence and accommodation tools do different things, and you generally need both.

A Practical Framework for Evaluating Any Intervention

The tool gives you a filter you can apply to literally anything you’re considering spending money on for ADHD. Here’s how I use it:

Before buying: Search the intervention at ebiadhd-database.org. Note the certainty rating and the effect size for the outcome you actually care about. A supplement might show effects on hyperactivity but not on attention, inattentive subtype, or emotional regulation. Know what you’re actually getting.

After looking it up: Ask whether the evidence level matches what you’re being charged. High-certainty, medium-effect interventions can justify real investment. Low-certainty, small-effect interventions probably shouldn’t cost you $150/month.

Keep using what works. Weak population-level evidence doesn’t mean something doesn’t work for your specific brain. But holding that belief clearly (“I’m using this despite thin evidence because it works for me”) is different from believing you’ve found a cure the establishment is hiding.

This isn’t about optimizing for perfect evidence-based purity. It’s about making decisions with accurate information instead of whoever had the most compelling Reddit thread this week.

The Featured-Snippet Version

What ADHD treatments have the strongest evidence (adults)?

1. Stimulant medications (methylphenidate, amphetamines) — high certainty, medium-large effects
2. Atomoxetine — moderate-to-high certainty, medium effects
3. CBT for adults — moderate-to-high certainty, medium effects

Non-medication options with some evidence:

• Mindfulness: large effects at extended follow-up, but low certainty
• Exercise: limited evidence, useful as adjunct

Low or insufficient evidence:

• Omega-3 for core symptoms
• Neurofeedback (effects largely disappear vs. active controls)
• Most supplements marketed for ADHD

Important caveat: Almost no high-certainty long-term evidence exists for any ADHD intervention. All strong evidence covers weeks to months.

---

One action: Go to ebiadhd-database.org right now and look up one thing you’re currently spending time or money on. Check the certainty rating. That’s it. Five minutes, and you’ll know more about what you’re working with than most ADHD patients do.

If it comes up with high certainty evidence, great. You’re doing something with real support behind it. If it comes up low, that’s not a mandate to quit. It’s just accurate information. Which is the thing we’ve always deserved and rarely had.

---

The study, “Benefits and harms of ADHD interventions: umbrella review and platform for shared decision making,” was published in The BMJ (November 2025). The interactive platform launched in February 2026. Full data at ebiadhd-database.org.